Evidence map›Paper›PMID 25689818›Full record

ReviewProgress in neuro-psychopharmacology & biological psychiatry2016

Hypothalamic neuropeptide signaling in alcohol addiction.

Jessica R Barson, Sarah F Leibowitz

Open access · greenAbstract readReview
In one paragraph

Review in Progress in neuro-psychopharmacology & biological psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Alternative use of suvorexant (BelsomraFrontiers in behavioral neuroscience · 2022
    Article
  16. The Sugars in Alcohol Cocktails Matter.ACS chemical neuroscience · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jessica R BarsonLaboratory of Behavioral Neurobiology, The Rockefeller University, 1230 York Avenue, Box 278, New York, NY 10065, USA. Electronic address: jbarson@rockefeller.edu.
Sarah F LeibowitzLaboratory of Behavioral Neurobiology, The Rockefeller University, 1230 York Avenue, Box 278, New York, NY 10065, USA. Electronic address: leibow@mail.rockefeller.edu.
Rockefeller University · US

Funding

HYPOTHALAMIC PEPTIDES IN THE CONTROL OF ALCOHOL INTAKER01AA012882 · NIAAA · ROCKEFELLER UNIVERSITY · PI LEIBOWITZ, SARAH F. · 2001 to 2015
$4.0M
Paraventricular thalamic nucleus: Role of orexin and opioids in ethanol intakeK99AA021782 · NIAAA · ROCKEFELLER UNIVERSITY · PI BARSON, JESSICA ROSE · 2013 to 2014
$265k
NIAAA NIH HHS K99 AA021782NIAAA NIH HHS K99AA021782NIAAA NIH HHS R01 AA012882NIAAA NIH HHS R01AA12882
6 · The paper itself

Abstract

The hypothalamus is now known to regulate alcohol intake in addition to its established role in food intake, in part through neuromodulatory neurochemicals termed neuropeptides. Certain orexigenic neuropeptides act in the hypothalamus to promote alcohol drinking, although they affect different aspects of the drinking response. These neuropeptides, which include galanin, the endogenous opioid enkephalin, and orexin/hypocretin, appear to stimulate alcohol intake not only through mechanisms that promote food intake but also by enhancing reward and reinforcement from alcohol. Moreover, these neuropeptides participate in a positive feedback relationship with alcohol, whereby they are upregulated by alcohol intake to promote even further consumption. They contrast with other orexigenic neuropeptides, such as melanin-concentrating hormone and neuropeptide Y, which promote alcohol intake under limited circumstances, are not consistently stimulated by alcohol, and do not enhance reward. They also contrast with neuropeptides that can be anorexigenic, including the endogenous opioid dynorphin, corticotropin-releasing factor, and melanocortins, which act in the hypothalamus to inhibit alcohol drinking as well as reward and therefore counter the ingestive drive promoted by orexigenic neuropeptides. Thus, while multiple hypothalamic neuropeptides may work together to regulate different aspects of the alcohol drinking response, excessive signaling from orexigenic neuropeptides or inadequate signaling from anorexigenic neuropeptides can therefore allow alcohol drinking to become dysregulated.

Indexed as

AlcoholismAnimalsHumansHypothalamusNeuropeptidesNeuropeptidesDynorphinEnkephalinGalaninMelanin-concentrating hormoneNeuropeptide YOrexin/hypocretin

Identifiers

PMID25689818
PMCPMC4537397
OpenAlexW2081987652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.